Literature DB >> 26926181

Barrier protective effect of asiatic acid in TNF-α-induced activation of human aortic endothelial cells.

Lai Yen Fong1, Chin Theng Ng1, Zhi Li Cheok1, Mohamad Aris Mohd Moklas2, Muhammad Nazrul Hakim1, Zuraini Ahmad3.   

Abstract

BACKGROUND: Endothelial cell activation is characterized by increased endothelial permeability and increased expression of cell adhesion molecules (CAMs). This allows monocyte adherence and migration across the endothelium to occur and thereby initiates atherogenesis process. Asiatic acid is a major triterpene isolated from Centella asiatica (L.) Urban and has been shown to possess anti-oxidant, anti-hyperlipidemia and anti-inflammatory activities.
PURPOSE: We aimed to investigate protective effects of asiatic acid on tumor necrosis factor-α (TNF-α)-induced endothelial cell activation using human aortic endothelial cells (HAECs). STUDY
DESIGN: For cell viability assays, HAECs were treated with asiatic acid for 24 h. For other assays, HAECs were pretreated with various doses of asiatic acid (10-40 µM) for 6 h followed by stimulation with TNF-α (10 ng/ml) for 6 h.
METHODS: Fluorescein isothiocyanate (FITC)-dextran permeability assay was performed using commercial kits. Total protein expression of CAMs such as E-selectin, ICAM-1, VCAM-1 and PECAM-1 as well as phosphorylation of IκB-α were determined using western blot. The levels of soluble form of CAMs were measured using flow cytometry. Besides, we also examined the effects of asiatic acid on U937 monocyte adhesion and monocyte migration in HAECs using fluorescent-based assays.
RESULTS: Asiatic acid significantly suppressed endothelial hyperpermeability, increased VCAM-1 expression and increased levels of soluble CAMs (sE-selectin, sICAM-1, sVCAM-1 and sPECAM-1) triggered by TNF-α. Neither TNF-α nor asiatic acid affects PECAM-1 expression. However, asiatic acid did not inhibit TNF-α-induced increased monocyte adhesion and migration. Interestingly, asiatic acid suppressed increased phosphorylation of IκB-α stimulated by TNF-α.
CONCLUSION: These results suggest that asiatic acid protects against endothelial barrier disruption and this might be associated with the inhibition of NF-κB activation. We have demonstrated a novel protective role of asiatic acid on endothelial function. This reveals the possibility to further explore beneficial effects of asiatic acid on chronic inflammatory diseases that are initiated by endothelial cell activation.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Asiatic acid; Cell adhesion molecules; Human aortic endothelial cells; NF-κB; TNF-α

Mesh:

Substances:

Year:  2016        PMID: 26926181     DOI: 10.1016/j.phymed.2015.11.019

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

Review 2.  Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review.

Authors:  Farshad Abedi Torbati; Mahin Ramezani; Reza Dehghan; Mohammad Sadegh Amiri; Ali Tafazoli Moghadam; Neda Shakour; Sepideh Elyasi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Protective effect of asiatic acid in an experimental cerulein-induced model of acute pancreatitis in mice.

Authors:  Wenqin Xiao; Weiliang Jiang; Kai Li; Yangyang Hu; Sisi Li; Li Zhou; Rong Wan
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

4.  Protective Effects of Alternanthera sessilis Ethanolic Extract against TNF-α or H2O2-Induced Endothelial Activation in Human Aortic Endothelial Cells.

Authors:  Nur Nadia Mohd Razali; Soek Sin Teh; Siau Hui Mah; Yoke Keong Yong; Chin Theng Ng; Yang Mooi Lim; Lai Yen Fong
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-24       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.